|
There's been a major development for weight loss drugs being used in the fight against obesity.
The World Health Organisation has backed GLP-1 drugs like Ozempic and Mounjaro to be used in the treatment of this major health problem, albeit with conditions. As Sarah Booth reports, the medications are still inaccessible to many in Australia.
See what it all means here. But the updated advice from the peak global body comes amid
warnings about the possibility of extremely serious side effects. There have also been hundreds of reports about a painful and potentially fatal condition called pancreatitis.

Meanwhile, if you think there's nothing feta than cheese, you'll be grateful for this comprehensive report. This week the Shopping Swaps series is focused on cheese. If you've ever wondered which types are lowest in salt, highest in protein or best for your gut health,
you can find answers here. We were also thrilled for medical editor Robyn Riley
who was awarded a prestigious Walkley Award for her expose on a baby being born to the wrong mother in a huge IVF mix-up. She won the All Media: Scoop of the Year category in the nation’s top journalism awards last Thursday night for the
exclusive story that made headlines around the world and led to tighter scrutiny of the IVF industry. Have a great week.
|